These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1948 related articles for article (PubMed ID: 8402733)

  • 1. Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages.
    Black PL; Phillips H; Tribble HR; Pennington R; Schneider M; Talmadge JE
    Cancer Immunol Immunother; 1993 Oct; 37(5):299-306. PubMed ID: 8402733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.
    Black PL; Phillips H; Tribble HR; Pennington R; Schneider M; Talmadge JE
    J Cell Biochem; 1988 Apr; 36(4):377-92. PubMed ID: 3132467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
    Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
    Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.
    Yeoman H; Robins RA
    Immunology; 1988 Feb; 63(2):291-7. PubMed ID: 2965096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma.
    Nakajima I; Chu TM
    Mol Biother; 1990 Dec; 2(4):228-32. PubMed ID: 2126942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing mice.
    Itoh T; Sakata Y; Yoshida Y; Tsushima K; Suzuki H; Saitoh S; Tamura Y; Ogasawara H; Sugimoto N; Takemori H
    Cancer Immunol Immunother; 1990; 32(2):88-94. PubMed ID: 2126986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro.
    Findley HW; Nasr S; Afify Z; Hnath R; Waldrep K; Ragab AH
    Cancer Invest; 1990; 8(5):493-500. PubMed ID: 2124946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition.
    Li Q; Nagahara N; Takahashi H; Takeda K; Okumura K; Minami M
    Toxicology; 2002 Apr; 172(3):181-90. PubMed ID: 11893417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity inhibition of cytolytic lymphocytes by omeprazole.
    Scaringi L; Cornacchione P; Fettucciari K; Rosati E; Rossi R; Marconi P; Capodicasa E
    Scand J Immunol; 1996 Sep; 44(3):204-14. PubMed ID: 8795713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.
    Gately MK; Warrier RR; Honasoge S; Carvajal DM; Faherty DA; Connaughton SE; Anderson TD; Sarmiento U; Hubbard BR; Murphy M
    Int Immunol; 1994 Jan; 6(1):157-67. PubMed ID: 7908534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of NK cell function during tumor growth favors Type 2-associated macrophages, leading to suppressed CTL generation.
    Geldhof AB; van Ginderachter JA; Liu Y; Noël W; de Baetselier P
    Clin Dev Immunol; 2003; 10(2-4):71-81. PubMed ID: 14768937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.